Timo Kylmälä

Effect of oral clodronate on bone pain

Inkeri Elomaa, Timo Kylmälä, Teuvo L.J. Tammela et al. · International Urology and Nephrology · 1992 · 119 citations

Medicine, Oral Medicine, Bone Metabolism +9

Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer

Timo Kylmälä, TLJ Tammela, Leila Risteli et al. · British Journal of Cancer · 1995 · 96 citations · Full text

Medicine, Cancer Biology, Oncology +17

Concomitant i.v. and oral clodronate in the relief of bone pain – a double-blind placebo-controlled study in patients with prostate cancer

Timo Kylmälä, T. Taube, TLJ Tammela et al. · British Journal of Cancer · 1997 · 91 citations · Full text

Medicine, Oncology, Pain Management +7

Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the finnish prostate cancer group

Timo Kylmälä, Teuvo L.J. Tammela, Leila Risteli et al. · European Journal of Cancer · 1993 · 71 citations

Medicine, Oncology, Pharmacology +13

The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer.

Timo Kylmälä, Teuvo L.J. Tammela, T. Sam Lindholm et al. · PubMed · 1994 · 44 citations

Medicine, Pharmacology, Pharmacotherapy +17